Pancreatic Neoplasms, Pancreatitis
Conditions
Keywords
pancreatic surgery, snapshot, global surgery, predictors, outcomes
Brief summary
Snapshot study worldwide over 3 months in 2021. Provide a verified record of true morbidity and mortality. Identify modifiable predicting factors of outcome. Obtain PubMed citable co-authorship,
Detailed description
The PancreasGroup.org team is conducting a snapshot clinical study investigating the outcomes of pancreatic surgery worldwide. This collaborative model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time. There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery. The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.
Interventions
PROCEDUREPancreatic surgery
Open, laparoscopic or robotic surgery of the pancreas
Sponsors
University College London Hospitals
Massachusetts General Hospital
Royal Free Hospital NHS Foundation Trust
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All indications (including benign and malignant) * Open, laparoscopic or robotic. * Elective or emergency. * Partial or total pancreatectomies. * Pancreatic tumour enucleations. * Procedures with concomitant vascular or other organ resections. * Pancreatic duct drainage procedures (e.g. Frey, Puestow, or Beger) * Adults 18 years of age or older.
Exclusion criteria
* Pancreas or islet cell transplantation. * Transcutaneous or transgastric imaging-guided ablation (e.g. RFA) or electroporation (e.g. NanoKnife). * Endoscopic (e.g. endoscopic retrograde cholangiopancreatography, stent or lithotripsy) procedures. * Endoscopic transgastric and surgical necrosectomies excluded. * Patients less than 18 years of age excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 90 days postoperatively | Postoperative death |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Morbidity | 90 days postoperatively | Postoperative complication rates classified according to Clavien-Dindo |
Contacts
Primary ContactGuiseppe K Fusai, MD, MS
Backup ContactDimitri A Raptis, MD, MSc, PhD
Outcome results
None listed